You have 9 free searches left this month | for more free features.

Condition

Diabetic Macular Edema (DME) (1)

Healthy Volunteers (1)

Neovascular Age-Related Macular Degeneration (nAMD) (1)

Wet Age-related Macular Degeneration (1)

Overall Status

Not yet recruiting (2)

Recruiting (1)

Sign in for free

Phase

phase 2 (2)

phase 1 (1)

Sponsor

Kyowa Kirin, Inc. (2)

Kyowa Kirin Co., Ltd. (1)

Collaborator

Intervention

khk4951 (3)

aflibercept injection (2)

placebo (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

khk4951

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Healthy Volunteers, Wet Age-related Macular Degeneration Trial in Fukuoka (Placebo, KHK4951)

Recruiting

Healthy Volunteers
Wet Age-related Macular Degeneration

Placebo
KHK4951

Fukuoka, Japan

Hakata clinic

Nov 10, 2021

Neovascular Age-Related Macular Degeneration (nAMD) Trial in Worldwide (KHK4951, Aflibercept Injection)

Not yet recruiting

Neovascular Age-Related Macular Degeneration (nAMD)

KHK4951
Aflibercept Injection

Arcadia, California
+27 more

Oct 31, 2023

Diabetic Macular Edema (DME) Trial in Worldwide (KHK4951, Aflibercept Injection)

Not yet recruiting

Diabetic Macular Edema (DME)

KHK4951
Aflibercept Injection

Arcadia, California
+29 more

Oct 31, 2023